Back to search

Netherlands· NL-8c6679c7a78f

Brivaracetam Glenmark 100 mg filmomhulde tabletten

A brivaracetam product containing brivaracetam, registered in Netherlands by Glenmark Arzneimittel GmbH. The same ATC class is registered in 18 of our 19 countries.

ATC N03AX23

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBrivaracetam Glenmark 100 mg filmomhu…ATCN03AX23REGISTER NO.NL-8c6679c7a78fPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Brivaracetam is registered in 18 of 19 countries.

Countries holding a registration under ATC N03AX23 (brivaracetam), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose

Brivaracetam · ATC N03AX23

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of brivaracetam costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $2.61 in France to $22.97 in Switzerland — a ×8.8 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Brivaracetam · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$22.97
  • IT Italy$3.99
  • FR France$2.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BRIVARACETAM
Manufacturer
Glenmark Arzneimittel GmbH
Country
Netherlands (NL)
ATC code
N03AX23
ATC class
Brivaracetam
Defined daily dose
0.1 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    132935

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

91 interactions on record for brivaracetam.

Graded by severity as the source publishes them — 63 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Brivaracetam · interactions on record

91 records

  • 63 moderate
  • 28 minor

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Brivaracetam in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All brivaracetam products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Abavalex, Brivaracetam Genericon
  • Belgium · Brivaracetam Teva
  • Bulgaria · Abavalex
  • Cyprus · Brivaracetam Accord
  • Czechia · Abavalex, Breluncol
  • Germany · Abavalex, Brivaracetam 1 A Pharma
  • Denmark · Abavalex, Brivaracetam Cipla
  • Spain · Brivaracetam Cinfa, Brivaracetam Combix
  • Finland · Brabela, Brivaracetam Desitin
  • France · Brivaracetam Biogaran, Brivaracetam La Colina
  • United Kingdom (Northern Ireland) · Brivaracetam Alissa, Brivaracetam Altair
  • Greece · Brivaracetam Anabiosis, Brivaracetam Anfarm
  • Croatia · Brivaracetam Accord, Brytyn
  • Hungary · Abavalex, Breluncol
  • Ireland · Brivaracetam Clonmel
  • Iceland · Brivaracetam, Brivaracetam Stada
  • Italy · Brileps, Brivaracetam Amarox
  • Liechtenstein · Briviact
  • Malta · Brivaracetam Anfarm, Brivaracetam Clonmel
  • Norway · Brivaracetam Desitin, Brivaracetam Glenmark
  • Poland · Abavalex, Brabela
  • Portugal · Brabela, Brivaracetam Anfarm
  • Romania · Abavalex, Breluncol
  • Sweden · Abavalex, Brivaracetam Amarox
  • Slovenia · Clizay
  • Slovakia · Abavalex, Breluncol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/de783653-6c0b-44d6-b19a-9f63c39e14c8
GET /v1/drugs/de783653-6c0b-44d6-b19a-9f63c39e14c8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132935_smpc.pdf",
  "strength": null,
  "atc_label": "Brivaracetam",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132935",
  "excipients": [
    "CALCIUMCARBONAAT (E 170)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "POLYVINYLALCOHOL (E 1203)",
    "TALK (E 553b)"
  ],
  "substances": [
    "BRIVARACETAM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132935.pdf",
  "authorised_at": "2025/04/10",
  "procedure_number": "SE/H/2541/005",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132935",
  "additional_monitoring": "N"
}

See everything about brivaracetam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.